Jacquelyn van Dam, MD
Physical Medicine & Rehabilitation · West Columbia, SCNPI 1477703940
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Forte Bio-pharma LLC at 26.7% of the total. Reporting peaked in 2019 at $121 and has fallen 89.1% since, to $13 in 2024.
Across 17 payments — averaging $21.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Forte Bio-pharma LLC$100
- Amgen$52
- Avanos Medical$51
- Arbor Pharmaceuticals, Inc.$42
- Surgalign Spine Technologies, Inc.$28
- Orthogenrx Inc.$22
- plus $79 from 5 others
What the payments were for
- Food & beverage$373100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Forte Bio-pharma LLC | 2 | $100 |
| Amgen | 3 | $52 |
| Avanos Medical | 2 | $51 |
| Arbor Pharmaceuticals, Inc. | 3 | $42 |
| Surgalign Spine Technologies, Inc. | 1 | $28 |
| Orthogenrx Inc. | 1 | $22 |
| Pacira Therapeutics, Inc. | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| AbbVie | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Zimmer Biomet | 1 | $14 |
How this compares
$373 in reported general payments places this provider in the 60th percentile of 122 physical medicine & rehabilitation providers in South Carolina.
See all physical medicine & rehabilitation providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 90 | $921 |
| Diclofenac Sodium | 48 | $500 |
| Meloxicam | 94 | $257 |
| Celecoxib | 16 | $149 |
| Ibuprofen | 14 | $141 |
| Naproxen | 12 | $56 |
| Tramadol Hcl | 24 | $44 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in West Columbia
- William LorenzFlorence$66K
- Charles NivensBluffton$25K
- Jonathan ChapekisGreer$17K
- Rebecca HoldrenGreenville$15K
- Nancey TsaiHanahan$13K
- Ashley MaybinConway$10K
- Anthony AlexanderFlorence$10K
- Eleasa HulonGreenville$10K
- Susan CramerBluffton$7K
- Christopher MerrellN Charleston$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.